Phytoalexins: What have we learned after 60 years?

被引:382
|
作者
Hammerschmidt, R [1 ]
机构
[1] Michigan State Univ, Dept Bot & Plant Pathol, E Lansing, MI 48824 USA
关键词
phytoalexin; active defense; secondary metabolism; disease resistance;
D O I
10.1146/annurev.phyto.37.1.285
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
One of the best and longest-studied defense response of plants to infection is the induced accumulation of antimicrobial, low-molecular-weight secondary metabolites known as phytoalexins. Since the phytoalexin hypothesis was first proposed in 1940, a role for these compounds in defense has been revealed through several experimental approaches. Support has come, for example, through studies on the rate of phytoalexins in relation to cessation of pathogen development, quantification of phytoalexins at the infection site, and relationship of pathogen virulence to the phytoalexin tolerance. Evidence in support of phytoalexins in resistance as well some recent advances in phytoalexin biosynthesis are reviewed. Criteria for evaluating a role for phytoalexins in disease resistance are also discussed.
引用
收藏
页码:285 / 306
页数:22
相关论文
共 50 条
  • [1] Mathematics Anxiety: What Have We Learned in 60 Years?
    Dowker, Ann
    Sarkar, Amar
    Looi, Chung Yen
    FRONTIERS IN PSYCHOLOGY, 2016, 7
  • [2] ECT after 70 years: What have we learned?
    Fink, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S88 - S88
  • [3] BSE: What have we learned after 18 years?
    Sly, T
    JOURNAL OF ENVIRONMENTAL HEALTH, 2004, 66 (10) : 40 - 40
  • [4] Chernobyl - After 15 years what have we learned?
    Howe, GR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U68 - U68
  • [5] Ten years after the crash: what have we learned?
    Behringer, Jan
    Gechert, Sebastian
    Onaran, Ozlem
    Rehm, Miriam
    Hein, Eckhard
    EUROPEAN JOURNAL OF ECONOMICS AND ECONOMIC POLICIES-INTERVENTION, 2019, 16 (02): : 176 - 178
  • [6] Three Years After CARMENA: What Have We Learned?
    Roussel, Eduard
    Beuselinck, Benoit
    Albersen, Maarten
    EUROPEAN UROLOGY, 2021, 80 (04) : 425 - 427
  • [7] Thirty years after the bupivacaine controversy: what have we learned?
    Shannon, James
    Douglas, Joanne
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2010, 57 (04): : 289 - 292
  • [8] Five years after to err is human - What have we learned?
    Leape, LL
    Berwick, DM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (19): : 2384 - 2390
  • [9] Omalizumab: What have we learned after ten years of prescription?
    Pradere, P.
    Garcia, G.
    Humbert, M.
    Aubier, M.
    Taille, C.
    REVUE DES MALADIES RESPIRATOIRES, 2016, 33 (02) : 117 - 127
  • [10] Emerging Infections: What Have We Learned After 15 Years?
    Heymann, D.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E36 - E36